Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features.

Juliette SvahnPhilippe PetiotJean-Christophe AntoineChristophe VialEmilien DelmontKarine VialaAndreas J SteckArmelle MagotCecile CauquilAline ZareaAndoni Echaniz-LagunaRuxandra Iancu FerfogliaAntoine GueguenLaurent MagyJean-Marc LégerThierry KuntzerKarine FerraudArnaud LacourJean-Philippe Camdessanchénull null

Published in: Journal of neurology, neurosurgery, and psychiatry (2017)

Our study highlights the extended clinical spectrum of patients with anti-MAG neuropathy, which appears unrelated to antibody titre. Besides, it may also suggest beneficial use of rituximab in the early phase of anti-MAG neuropathy.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
diffuse large b cell lymphoma
patient reported outcomes